244.55
Precedente Chiudi:
$242.83
Aprire:
$242.22
Volume 24 ore:
1.37M
Relative Volume:
1.05
Capitalizzazione di mercato:
$33.75B
Reddito:
$1.96B
Utile/perdita netta:
$-253.24M
Rapporto P/E:
-128.63
EPS:
-1.9012
Flusso di cassa netto:
$94.06M
1 W Prestazione:
+2.40%
1M Prestazione:
+22.32%
6M Prestazione:
+47.76%
1 anno Prestazione:
+44.69%
Natera Inc Stock (NTRA) Company Profile
Nome
Natera Inc
Settore
Industria
Telefono
650-249-9090
Indirizzo
13011 MCCALLEN PASS, AUSTIN, CA
Confronta NTRA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
NTRA
Natera Inc
|
244.55 | 33.41B | 1.96B | -253.24M | 94.06M | -1.9012 |
|
TMO
Thermo Fisher Scientific Inc
|
572.77 | 216.12B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.25 | 160.43B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.10 | 57.29B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
145.49 | 41.98B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
225.85 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-27 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Ripresa | Wells Fargo | Equal Weight |
| 2025-03-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-23 | Iniziato | Barclays | Overweight |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-08 | Ripresa | Craig Hallum | Buy |
| 2024-02-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Reiterato | BTIG Research | Buy |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-11-13 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Iniziato | Bernstein | Mkt Perform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-05 | Iniziato | UBS | Buy |
| 2023-01-18 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-04-25 | Iniziato | Stephens | Overweight |
| 2022-03-08 | Iniziato | Goldman | Buy |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-06-15 | Iniziato | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Wells Fargo | Overweight |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-09-28 | Iniziato | Morgan Stanley | Overweight |
| 2020-09-17 | Iniziato | SVB Leerink | Outperform |
| 2020-06-10 | Ripresa | Piper Sandler | Overweight |
| 2020-05-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Iniziato | JP Morgan | Neutral |
| 2018-07-05 | Reiterato | Piper Jaffray | Overweight |
| 2017-08-07 | Reiterato | Morgan Stanley | Overweight |
| 2016-11-10 | Reiterato | The Benchmark Company | Buy |
| 2016-05-23 | Reiterato | The Benchmark Company | Buy |
| 2016-05-11 | Reiterato | The Benchmark Company | Buy |
| 2016-04-19 | Iniziato | The Benchmark Company | Buy |
| 2015-09-28 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2015-08-14 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Iniziato | Robert W. Baird | Outperform |
| 2015-07-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Iniziato | Piper Jaffray | Overweight |
| 2015-07-27 | Iniziato | Wedbush | Neutral |
Mostra tutto
Natera Inc Borsa (NTRA) Ultime notizie
Natera Makes High-Conviction Moves to Seize the Lucrative Oncology Frontier; Will It Succeed? - Smartkarma
Federated Hermes Inc. Has $129.71 Million Position in Natera, Inc. $NTRA - MarketBeat
Jump Financial LLC Purchases 18,821 Shares of Natera, Inc. $NTRA - MarketBeat
Invesco Ltd. Sells 165,294 Shares of Natera, Inc. $NTRA - MarketBeat
Natera acquires Foresight Diagnostics to expand cancer detection capabilities By Investing.com - Investing.com Nigeria
Should Natera’s (NTRA) New Share Offering and Signatera Lymphoma Data Require Action From Investors? - simplywall.st
Dir Chapman Files To Sell 4,366 Of Natera Inc [NTRA] - TradingView
Natera envisions cancer-testing future with $450M Foresight buy - BioWorld MedTech
Boulder diagnostics co. bought by Austin biotech giant in $450M deal - The Business Journals
Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal? - Benzinga
Working capital per share of Natera, Inc. – DUS:45E - TradingView
Natera buys Foresight Diagnostics in $450M cancer testing deal - Fierce Biotech
Austin biotech giant Natera acquires Colorado diagnostics company - The Business Journals
Natera (NASDAQ:NTRA) Hits New 1-Year HighWhat's Next? - MarketBeat
Natera Buys Foresight To Boost Super-Early Cancer Detection Tech - Benzinga
Natera Acquires Foresight Diagnostics - Contract Pharma
ETFs Investing in Natera, Inc. Stocks - TradingView
Natera Acquires Foresight Diagnostics for $275 Million - TipRanks
Natera Completes Foresight Diagnostics Acquisition in All-Stock Deal - marketscreener.com
Natera acquires Foresight Diagnostics - marketscreener.com
Natera stock reaches all-time high of 241.36 USD By Investing.com - Investing.com Nigeria
Steven Leonard Chapman Sells 4,400 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Solomon Moshkevich Sells 3,000 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera, Inc. Earnings and Revenue – GETTEX:45E - TradingView
Net income of Natera, Inc. – GETTEX:45E - TradingView
Natera (NTRA): Assessing Valuation After a Powerful Multi‑Month Share Price Rally - Yahoo Finance
Natera stock reaches all-time high of 241.36 USD - Investing.com
Natera Inc: President Moshkevich sells $714k in stock By Investing.com - Investing.com South Africa
New York State Common Retirement Fund Raises Holdings in Natera, Inc. $NTRA - MarketBeat
XTX Topco Ltd Sells 34,439 Shares of Natera, Inc. $NTRA - MarketBeat
A Look At The Intrinsic Value Of Natera, Inc. (NASDAQ:NTRA) - Yahoo Finance
Edgestream Partners L.P. Grows Stock Position in Natera, Inc. $NTRA - MarketBeat
Arrowstreet Capital Limited Partnership Raises Position in Natera, Inc. $NTRA - MarketBeat
Insider Sell: Solomon Moshkevich Sells 3,000 Shares of Natera In - GuruFocus
Natera Inc: President Moshkevich sells $714k in stock - Investing.com
Natera CEO Chapman sells $1.05 million in stock - Investing.com
Natera CEO Chapman sells $1.05 million in stock By Investing.com - Investing.com UK
Officer Moshkevich Sells 3,000 ($714.5K) Of Natera Inc [NTRA] - TradingView
Natera, Inc.: Revenue and Earnings Analysts Forecasts Revisions | 45E | US6323071042 - marketscreener.com
Natera, Inc.: Dividend historical data and projections - marketscreener.com
Natera (NTRA): Valuation Check After ASH Signatera Lymphoma Data Fuels Hematology Growth Optimism - simplywall.st
NTRA: Double-digit MRD growth, broad Signatera adoption, and new clinical data drive future expansion - TradingView
Natera (NASDAQ: NTRA) to Present 144-Patient Lymphoma Signatera Data at ASH 2025 - Stock Titan
Panagora Asset Management Inc. Grows Stake in Natera, Inc. $NTRA - MarketBeat
Schroder Investment Management Group Reduces Stock Position in Natera, Inc. $NTRA - MarketBeat
Russell Investments Group Ltd. Lowers Position in Natera, Inc. $NTRA - MarketBeat
Hsbc Holdings PLC Trims Stock Position in Natera, Inc. $NTRA - MarketBeat
Morgan Stanley Raises Natera (NTRA) Price Target with Overweight Rating | NTRA Stock News - GuruFocus
Morgan Stanley assumes coverage on Natera stock with Overweight rating By Investing.com - Investing.com Nigeria
Natera to Present 12 Datasets Including >50,000 Patients Featuring Signatera™ at the San Antonio Breast Cancer Symposium - Yahoo Finance
Pura Vida Investments LLC Boosts Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Inc Azioni (NTRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):